The total number of records retrieved from this search are 3. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
OV_5422	Vaccinia virus	LIVP-GFP	DNA	Poxviridae	Deletion mutant for tk gene	Yes	No	No	Russian academy of science	Human cervical carcinoma	KB-3-1	9.0E+3 cells per well	NA	MTT assay	1 MOI	64% cell viability after 24 hours	No	No	NA	No response	NA	Reduction production of IL-6 indicating tumor inhibition	NA	NA	27538520
OV_5423	Vaccinia virus	LIVP-GFP	DNA	Poxviridae	Deletion mutant for tk gene	Yes	No	No	Russian academy of science	Human cervical carcinoma	KB-3-1	9.0E+3 cells per well	NA	MTT assay	1 MOI	40% cell viability after 48 hours	No	No	NA	No response	NA	Reduction production of IL-6 indicating tumor inhibition	NA	NA	27538520
OV_5424	Vaccinia virus	LIVP-GFP	DNA	Poxviridae	Deletion mutant for tk gene	Yes	No	No	Russian academy of science	Human cervical carcinoma	KB-3-1	9.0E+3 cells per well	NA	MTT assay	1 MOI	17% cell viability after 72 hours	No	No	NA	No response	NA	Reduction production of IL-6 indicating tumor inhibition	NA	NA	27538520